Show All

Shares of GE HealthCare are listed on The Nasdaq Stock Market under the ticker symbol “GEHC.”

The CUSIP number for GE HealthCare common stock is 36266G107.

Our corporate headquarters is located at:

500 W. Monroe Street
Chicago, Illinois 60661
Phone: (617) 443-3400

GE HealthCare is incorporated in Delaware.

The transfer agent and registrar for our common stock is Equiniti Trust Company.

Registered shareholders with questions relating to the mechanics of the Spin-Off, should contact the distribution agent at:

Regular Mail Delivery:
Equiniti Trust Company
P.O. Box 64854
Saint Paul, Minnesota 55164-0854

Overnight Mail Delivery:
Equiniti Trust Company
Attn: Account Management Team
1110 Centre Pointe Curve, Suite 101
Mendota Heights, Minnesota 55120-4101

www.shareowneronline.com
(833) 914-2122 (toll free)
(651) 450-4064 (international number)

The Spin-off is effective as of 5:00 p.m., EST, on January 3, 2023, which we refer to as the “Distribution Date.”

Capital location policy, including a dividend, will be discussed with the Board of Directors post spin.

Deloitte & Touche LLP is the Company’s independent auditor.

The Company’s fiscal year end will be on December 31.

GE HealthCare’s SEC filings can be found here.

More information on GE HealthCare’s governance framework can be found here.

You can reach our investor relations team through this contact form.

GE HealthCare’s global leadership team can be found here.

Our Board of Directors can be found here.

You can receive email alerts through this form.

The record date for the Spin-off was as of the close of business on December 16, 2022.

We expect that the intended distribution of GE HealthCare common stock will be tax-free to holders of GE common stock for U.S. federal income tax purposes. Foreign, as well as U.S. stockholders, should contact their own tax advisor with respect to the U.S. federal, state and local, and foreign tax consequences of the distribution.